Artiria is proud to announce it was selected to enter the "Scale up coaching" phase from the Innosuisse program, where we'll conduct a thorough analysis of our growth strategy to ensure optimal expansion.
We already successfully achieved the phase 1 and 2. #achievement#growth
More than 12 million people are affected by stroke every year.
It's important to recognise the early signs of a stroke and react quickly. Can include : sudden facial numbness, difficulty speaking and loss of balance.
Let's act together to prevent and raise awareness.
#stroke
Imagine every moment that counts against stroke. Crucial seconds not wasted, increased opportunities for survival and recovery.
Artiria Medical rises the challenge to revolutionize neurovascular care, unlocking a future of healing to save lives: https://t.co/8skf63GBfc
#Artiria
🚀 Great news!
Artiria brilliantly obtains the Innosuisse 🏆
Certificate, testifying to our commitment to innovation and sustainable growth.
Stay with us to follow our next advances and discoveries. ✨
#Artiria#Innovation#Certification
We are delighted to inform you that #Artiria will be present at the #ESMINT congress which will take place in Marseille, from September 04 to 06, 2023! 🎉
We look forward to welcoming you to the ESMINT congress and sharing our passion for medicine with you.
@esmintsociety
👏Congratulation to @ArtiriaM for their announcement ! 👏 Their real-time deflectable guidewire has been granted the 510(k) clearance by the U.S. Food and Drug Administration. This is a significant milestone for the company which will foster its clinical development. 👏
Big news! Artiria Medical received FDA 510(k) clearance for its real-time deflectable guidewire! We are looking forward to starting our clinical activities in the U.S., bringing our Swiss-made innovation closer to patients. #ArtiriaM#StrokeTreatment#MedTech
Very interesting and well written article from the #NYTimes on the more efficient treatment of #stroke through EVT.
We at Artiria medical thrive to accelerate these procedures even more.
Stroke kills about six and a half million people annually and is a leading cause of disability. A “miracle treatment” called endovascular thrombectomy can save stroke patients. But only if it is performed quickly enough — and there lies the real challenge. https://t.co/2kpHBdoD0K
Guillaume Petit-Pierre showcases efforts by @ArtiriaM to develop augmented neurovascular guidewires - stating that its technology forms a "bridge" between the present and the future in #INR + aiming for US FDA approval in 2023 #ESMINT2022@esmintsociety